Please login to the form below

Not currently logged in
Email:
Password:

Pharma Perspectives

This page shows the latest Pharma Perspectives news and features for those working in and with pharma, biotech and healthcare.

Power to the people

Power to the people

To progress, pharma needs to think differently about how it conducts patient research and to understand the nuance between research and insight. ... This ‘deep dive’into patients’perspectives does require pharma to shift from its traditional

Latest news

  • Introducing pharma perspectives Introducing pharma perspectives

    Introducing pharma perspectives. Matt de Gruchy outlines the HCC's forthcoming collaboration with PME. ... This need for industry executives and agency staff to work in harmony to conquer the emerging healthcare challenges is what sits behind 'Pharma

  • AbbVie uses art gallery in inflammation campaign AbbVie uses art gallery in inflammation campaign

    With'Perspectives – Art, Inflammation and Me', the pharma company hopes to add a different dimension to the understanding of immune-mediated inflammatory diseases (IMIDs) and their impact. ... week. Perspectives will also visit various art galleries

  • German healthcare reforms

    German healthcare reforms. Payer and pharma perspectives on what the changes mean.

  • Ties that bind

    Ties that bind. Payers give their perspectives on what pharma must do to build lasting, meaningful and mutually beneficial relationships. ... One area in which pharma can add significant value is through connecting stakeholders.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • We can be heroes We can be heroes

    Working closely with stakeholders helps pharma understand its customers’perspectives and environment, and deliver appropriate solutions - initiatives aligned with  value-based healthcare principles, for example, or supporting  patient-reported

  • Pharma Perspectives: The agency selection process (part 2) Pharma Perspectives: The agency selection process (part 2)

    Pharma Perspectives: The agency selection process (part 2). AstraZeneca's Samuel Hollis on the evolution of the agency selection process. ... Samuel Hollis is a business unit director at AstraZeneca. In Pharma Perspectives, published in association with

  • Pharma Perspectives: The agency selection process (part 1) Pharma Perspectives: The agency selection process (part 1)

    Pharma Perspectives: The agency selection process (part 1). S&H Group's David Higgins on the evolution of the agency selection process. ... In Pharma Perspectives, published in association with the HCC, senior industry and agency figures address key

  • Pharma perspectives: communications creativity (part 2) Pharma perspectives: communications creativity (part 2)

    Pharma perspectives: communications creativity (part 2). David Higgins from Sudler &Hennessey Group on what it means to be creative in healthcare communications. ... In the PME/PMLiVE series Pharma Perspectives with the HCC senior industry and agency

  • Pharma perspectives: communications creativity (part 1) Pharma perspectives: communications creativity (part 1)

    Pharma perspectives: communications creativity (part 1). AstraZeneca business unit director Samuel Hollis on what healthcare communications creativity means to him. ... In the PME/PMLiVE series Pharma Perspectives with the HCC senior industry and agency

More from intelligence
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Joint Working That Works

    Having delivered over 20 collaborative projects, we wanted to share what we’ ve learned and find out more about the perspectives of our pharma and NHS colleagues. ... Both pharma and clinicians see huge benefits to joint working. When it works well,

  • How can pharma deliver real value to doctors and earn their trust?

    shows only three per cent of doctors think that online pharma resources are credible and 42% never visit pharmaceutical websites. ... By gathering insights into doctors’ perceptions of the competitive landscape, knowledge levels and understanding of

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics